Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell or gene therapies for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

106

CIRM-FUNDED CLINICAL TRIALS

Disease AreasInvestigatorOrganizationPhaseTrial StatusTarget EnrollmentDetail
Blood Cancer
Solid Tumors		 Dr. Irving L Weissman MD Stanford University Phase 1 Completed 88
Brain Cancer Dr. Christine E. Brown City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 82
Brain Cancer Anthony J. Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 234
Brain Cancer
Breast Cancer		 Dr Saul J Priceman City of Hope, Beckman Research Institute Phase 1 Recruiting 39
Brain Cancer Dr. Leo D Wang City of Hope, Beckman Research Institute Phase 1 Recruiting 18
Brain Cancer Crystal Mackall Stanford University Phase 1 Recruiting 54
Brain Cancer Dr Jana Portnow City of Hope, Beckman Research Institute Phase 1 Launching N/A
Brain Cancer Dr. Reena Parada Thomas Stanford University Phase 1 Launching N/A
Brain Cancer Dr. Hideho Okada University of California, San Francisco Phase 1 Launching N/A
Colon Cancer Mark Chao Forty Seven Inc. Phase 1/2 Completed 78
Colon Cancer Ivan King Tachyon Therapeutics, Inc Phase 1 Launching N/A
Lung Cancer Steven M. Dubinett University of California, Los Angeles Phase 1 Recruiting 24
Melanoma Robert Dillman Caladrius Biosciences Phase 3 Closed 4
Melanoma
Skin cancer		 Dr. Antoni Ribas M.D., Ph.D. University of California, Los Angeles Phase 1 Closed 5
Melanoma Anusha Kalbasi Stanford University Phase 1 Launching N/A
Sarcoma Theodore Scott Nowicki University of California, Los Angeles Phase 1 Closed 5
Solid Tumors Dr. Dennis J Slamon University of California, Los Angeles Phase 1 Completed 46
Solid Tumors Dr. Pamela Reilly Contag BioEclipse Therapeutics INC. Phase 1 Recruiting 60
Solid Tumors Pei Wang Eureka Therapeutics, Inc. Phase 1/2 Launching N/A
Download as Excel